Europe

U.K. unemployment: the case for optimism

Thursday, March 1, 2012 06:01 AM

Dr. John Philpott, chief economic adviser at the Chartered Institute of Personnel and Development (CIPD), told the Yorkshire HR Directors Forum in Leeds on February 29 that even a relatively modest economic recovery in 2012 could see U.K. unemployment stabilize at around the current rate of 8.4%, while a stronger recovery has the potential to result in a sudden sharp fall in the jobless total.

More... »

Shire and arGEN-X enter therapeutic antibody alliance

Wednesday, February 29, 2012 04:12 PM

Netherlands-based arGEN-X has entered into an alliance with U.K.-based Shire Pharmaceuticals to create novel therapeutic antibody products against multiple targets submitted by the latter.

More... »

Lilly to invest $442 million in new biopharma facility in Ireland

Monday, February 27, 2012 03:18 PM

Eli Lilly is investing $442 million in a brand-new biopharmaceutical commercialization and manufacturing facility at its Kinsale campus in Cork, Ireland, according to Richard Bruton TD, minister for jobs, enterprise and innovation.

More... »

European Medicines Agency to start publishing info on drug applications

Wednesday, February 22, 2012 03:30 PM

Starting March 1, 2012, the European Medicines Agency will regularly publish information on applications for centralized marketing authorization for human medicines that it has received for evaluation.

More... »

New Academy gives Irish researchers a voice in policy making

Tuesday, February 14, 2012 11:46 AM

The European Commissioner for Research, Innovation and Science, Máire Geoghegan-Quinn, has launched a new Academy to bring together Ireland's leading medical researchers to promote excellence in biomedical research, with the ultimate aim of improving the health of the population.

More... »

EMA objects to Alexza’s Adasuve MAA

Tuesday, February 14, 2012 07:18 AM

Alexza Pharmaceuticals has received preliminary feedback, the Day 80 Assessment Report, from the European Medicines Agency (EMA) regarding its Marketing Authorization Application (MAA) for Adasuve, which seeks approval for the rapid control of agitation in adult patients with schizophrenia or bipolar disorder.

More... »

CoE launches eTACT to authenticate drugs with smartphones

Monday, February 13, 2012 03:11 PM

The Council of Europe (CoE) and its European Directorate for the Quality of Medicines & HealthCare (EDQM) have launched eTACT, an IT-based traceability service that will allow patients to check the authenticity of their medicines using smartphones or the internet.

More... »

Pepscan achieves milestones from Janssen

Saturday, February 11, 2012 07:53 AM

Pepscan Therapeutics, a Netherlands-based biotechnology firm focusing on protein mimicry technology, has achieved two milestones in the research collaboration with Janssen R&D Ireland, formerly Tibotec Pharmaceuticals, and received undisclosed payments. 

More... »

Lorediplon has best-in-class results for insomnia

Friday, February 10, 2012 03:38 PM

Ferrer, a privately-held Spanish pharmaceutical company, has released results from a phase I trial of Lorediplon in insomnia showing it has a best-in-class efficacy profile in terms of sleep maintenance and sleep quality when compared to market leader zolpidem.

More... »

GW receives Austrian approval for cannabis-based oral spray for MS

Friday, February 10, 2012 12:04 PM

GW Pharmaceuticals’ Sativex (THC and cannabidiol) oral spray has received regulatory approval in Austria as a treatment of spasticity due to Multiple Sclerosis (MS).

More... »